248 related articles for article (PubMed ID: 22145577)
1. Does octreotide prevent L-asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia?
Tokimasa S; Yamato K
Br J Haematol; 2012 May; 157(3):381-2. PubMed ID: 22145577
[No Abstract] [Full Text] [Related]
2. Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia.
Wu SF; Chen AC; Peng CT; Wu KH
Pediatr Blood Cancer; 2008 Dec; 51(6):824-5. PubMed ID: 18726919
[TBL] [Abstract][Full Text] [Related]
3. Successful use of octreotide as a chemoprotectant for prevention of PEG-asparaginase-induced pancreatitis.
Buie LW; Moore J; van Deventer H
Pharmacotherapy; 2014 Aug; 34(8):e149-51. PubMed ID: 25112526
[TBL] [Abstract][Full Text] [Related]
4. [Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase].
Wlazłowski M; Celińska W; Maciejka-Kapuścińska L; Płoszyńska A; Idczak E
Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):296-7. PubMed ID: 7808958
[TBL] [Abstract][Full Text] [Related]
5. Retherapy using L-asparaginase with octreotide in a patient recovering from L-asparaginase-induced pancreatitis.
Suzuki M; Takata O; Sakaguchi S; Fujimura J; Saito M; Shimizu T
Exp Hematol; 2008 Mar; 36(3):253-4. PubMed ID: 18279714
[No Abstract] [Full Text] [Related]
6. Pancreatic panniculitis caused by L-asparaginase induced acute pancreatitis in a child with acute lymphoblastic leukemia.
Chiewchengchol D; Wananukul S; Noppakun N
Pediatr Dermatol; 2009; 26(1):47-9. PubMed ID: 19250405
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic use of octreotide for asparaginase-induced acute pancreatitis.
Sakaguchi S; Higa T; Suzuki M; Fujimura J; Shimizu T
Int J Hematol; 2017 Aug; 106(2):266-268. PubMed ID: 28349445
[TBL] [Abstract][Full Text] [Related]
8. Successful Management of l-Asparaginase-Associated Pancreatitis With Octreotide and Pegylated Asparaginase in 2 Patients With Acute Lymphoblastic Leukemia: Is There a Different Rare Warning Sign of Hypoglycemia for l-Asparaginase-Associated Pancreatitis?
Aydin Köker S; Oymak Y; Demirağ B; Karapinar TH; Koker A; Genç S; Erdemir G; Vergin RC
Clin Ther; 2020 Apr; 42(4):e82-e86. PubMed ID: 32184014
[TBL] [Abstract][Full Text] [Related]
9. Successful management of severe L-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic.
Morimoto A; Imamura T; Ishii R; Nakabayashi Y; Nakatani T; Sakagami J; Yamagami T
Cancer; 2008 Sep; 113(6):1362-9. PubMed ID: 18661511
[TBL] [Abstract][Full Text] [Related]
10. Epileptic seizures after octreotide administration in a 6.5-year-old female with ALL and L-asparaginase associated pancreatitis: a possible drug interaction.
Hatzipantelis E; Pana ZD; Pavlou E; Balakou E; Tsotoulidou V; Papageorgiou T; Tragiannidis A; Athanassiadou F
Klin Padiatr; 2011 Nov; 223(6):360-3. PubMed ID: 22052632
[TBL] [Abstract][Full Text] [Related]
11. Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
Cohen H; Bielorai B; Harats D; Toren A; Pinhas-Hamiel O
Pediatr Blood Cancer; 2010 May; 54(5):703-6. PubMed ID: 20063421
[TBL] [Abstract][Full Text] [Related]
12. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.
Top PC; Tissing WJ; Kuiper JW; Pieters R; van Eijck CH
Pediatr Blood Cancer; 2005 Jan; 44(1):95-7. PubMed ID: 15368548
[TBL] [Abstract][Full Text] [Related]
13. [Acute pancreatitis secondary to L-asparaginase (a case report)].
Tazi I; Rachid M; Quessar A; Harif M; Benchekroun S
East Mediterr Health J; 2009; 15(2):475-9. PubMed ID: 19554997
[No Abstract] [Full Text] [Related]
14. Allogeneic bone marrow transplantation after L-asparaginase-induced pancreatitis in a patient with acute lymphoblastic leukemia.
Yamada Y; Ito K; Watanabe Y; Nosaka K; Horikawa K; Hidaka M; Kawano F; Sasaki Y; Mitsuya H; Asou N
Leuk Res; 2008 Dec; 32(12):1944-6. PubMed ID: 18502503
[No Abstract] [Full Text] [Related]
15. Octreotide prevents L-asparaginase-induced pancreatic injury in rats.
Suzuki M; Shimizu T; Kudo T; Shoji H; Ohtsuka Y; Yamashiro Y
Exp Hematol; 2008 Feb; 36(2):172-80. PubMed ID: 18023522
[TBL] [Abstract][Full Text] [Related]
16. Blood lipid profiles in children with acute lymphoblastic leukemia.
Halton JM; Nazir DJ; McQueen MJ; Barr RD
Cancer; 1998 Jul; 83(2):379-84. PubMed ID: 9669823
[TBL] [Abstract][Full Text] [Related]
17. Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol.
Raja RA; Schmiegelow K; Albertsen BK; Prunsild K; Zeller B; Vaitkeviciene G; Abrahamsson J; Heyman M; Taskinen M; Harila-Saari A; Kanerva J; Frandsen TL;
Br J Haematol; 2014 Apr; 165(1):126-33. PubMed ID: 24428625
[TBL] [Abstract][Full Text] [Related]
18. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
Hourani R; Abboud M; Hourani M; Khalifeh H; Muwakkit S
Neuropediatrics; 2008 Feb; 39(1):46-50. PubMed ID: 18504683
[TBL] [Abstract][Full Text] [Related]
19. Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia.
Earl M
Clin Adv Hematol Oncol; 2009 Sep; 7(9):600-6. PubMed ID: 20020672
[TBL] [Abstract][Full Text] [Related]
20. L-asparaginase induced intracranial haemorrhage in acute lymphoblastic leukemia.
Lim HL; Teo CP; Wong K; Kueh YK
Singapore Med J; 1998 Feb; 39(2):76-8. PubMed ID: 9652181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]